North America Kidney Transplant Market to be USD 14.7 Billion by 2027, Propelled by Increased Public Awareness of Organ Donation, and Favorable Reimbursement Policies
22 Feb, 2023

According to Renub Research latest report “North America Kidney Transplant Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth” North America Kidney Transplant Market is estimated to reach US$ 14.76 Billion by 2027. In recent times, the growth in demand for novel tissue transplantation products and organ transplantation for treatment of organ failure has increased immensely. As per the United Network for Organ Sharing (UNOS) organisation, there were 35,446 organ transplants that took place in 2022 (January-October), in North America. The North American public has the availability of advanced technologically advanced equipment’s, and the increasing expenditure in healthcare sector by the government.

A kidney transplant is a procedure where a healthy kidney is transferred from one person into the body of other person, whose kidneys no longer function properly. This loss of function of the kidney, is known as end-stage chronic kidney disease (ESRD). It is the most common reason for undergoing a kidney transplant. Chronic Kidney Disease is the 9th leading cause of death in the United States, and nearly 15% of the population is affected by it, according to the Council of Economic Advisors.

North America Kidney Transplant Market will grow at a CAGR of 5.38% during the Forecast Period (2022-2027):

A kidney transplant is not a cure, but it provides for the best possible medical improvement option available for people living with kidney failure. The rise in the demand for transplantation procedures globally adds to the growth of the market. For instance; in 2019, 4419 Canadians were on a waiting list for a transplant. Of those, 77% were waiting for a kidney. Currently, in United States, there are nearly 100,000 patients waiting for a kidney transplant, which is almost 84% of the total number of organ transplant patients, and the number of transplants performed every year is 20,000. Furthermore, factors like growing awareness in the population regarding organ donation, availability of a donors, and rise in research and development programs by government and private sectors, also aid the growth of the market.

Living Donor Transplant Segment is expected to grow at a Significant Rate over the Forecast Period (2022-2027):

The living donor transplant segment is forecasted to grow at a significant rate. About one-third of all kidney transplants performed in the U.S. are living-donor kidney transplants. This is as the living donor transplant takes place sooner, which could prevent possible complications and deterioration of health of the recipient, the kidney has less chances of rejection, better short- and long-term survival rates, and the transplant may be scheduled in advance once the donor is approved in comparison to an unscheduled, emergency transplant procedure with a deceased donor kidney. According to UNOS, in 2021, more than 6,500 transplants were made possible by living donors. The living donor transplants increased by 14.2% over the 2020 total. 

Calcineurin Inhibitors Segment is expected to dominate the Market Share:

The calcineurin inhibitors segment has a dominating market share. The high market share can be attributed to factors like, rise in healthcare infrastructure, increase in the cases of organ transplant, and increase in research and development activities. The antibodies segment is also expected have a significant market share. 

The United States is known for its developed healthcare infrastructure and extensive research activity, presence of modern healthcare infrastructure and the presence of leading market players, and increasing support from the government. These are some of the factors, which makes it a favourable market for antibodies.  Other factors that positively impact the antibodies market are, high prevalence of chronic diseases, growing aging population, high patient spending potential, and increasing incidence of cancers.

United States Kidney Transplant dominates the Market Share of the North America Kidney Transplant Market:

The reason for the United States market share dominance is significant demand for innovative tissue transplantation products and organ transplantation, adequate reimbursement plans, and the fast adoption of 3D bioprinting. The Mexico region has a low growth rate in the market. The reason for this is unequal access to kidney transplantation in Mexico and is restricted to patients with medical insurance. An inefficient organ procurement program resulted in low rates of deceased-donor kidneys. These inequalities can be overcome by the implementation of a comprehensive kidney care program, and recognizing kidney transplantation as the therapy of choice for renal failure.

Market Summary:

• Type - The Report covers North America Kidney Transplant Market, by type in 2 viewpoints (deceased donor transplant, and living donor transplant).
• Drugs - North America Kidney Transplant Market breakup by drugs in 5 viewpoints (calcineurin inhibitors, antiproliferative agents, mTor inhibitor, steroids, and antibodies).
• North America Market Share - Renub Research report covers North America, by market share in 3 viewpoints (United States, Canada, and Mexico).

About Us
Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us
Renub Research
Phone: +1-478-202-3244 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research